Agilent Technologies Announces First Microarray Certified Service Provider in Korea

17-Sep-2009 - Agilent Technologies Inc. announced DNA Link, Inc. has achieved Certified Service Provider status for Agilent microarray platform. Certification is for array-based comparative genomic hybridization (aCGH) and microRNA (miRNA) applications, both representing fast growing segments for the Agilent ...

Scil Proteins acquires Tat Phage display from ipal GmbH and Charité

17-Sep-2009 - Scil Proteins announced the signing of an agreement with ipal GmbH and Charité University Hospital, Berlin for the purchase of the Tat Phage display technique. Tat Phage display allows the precise selection of Affilin® therapeutics with high affinity and selectivity for disease targets from Scil ...

Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays

16-Sep-2009 - Ambry Genetics announced that they have completed certification to become an Agilent Certified Service Provider on the Agilent microarray platform. The initial certification is for Comparative Genomic Hybridization (aCGH) which is an application used by researchers to discover and detect genomic ...

Pieris AG enters into Anticalin Collaboration with Allergan, Inc.

16-Sep-2009 - Pieris AG announced that they have entered into a collaboration agreement with Allergan, Inc. that combines Pieris’ proprietary Anticalin technology with Allergan’s expertise in drug delivery and ophthalmic drug development with a goal of developing agents for the treatment of serious ocular ...

Fluidigm and Química Valaner team together in Mexican distribution deal

16-Sep-2009 - Fluidigm Corporation has appointed Química Valaner S.A de C.V as exclusive distributor for Fluidigm’s instrumentation and chips in Mexico. “Fluidigm is committed to bringing the accuracy and efficiency benefits of integrated fluidic circuit technology to life science researchers in Mexico,” ...

Olink Bioscience and Olink Genomics in a project aimed to improve cancer treatment

15-Sep-2009 - Olink Bioscience and its sister company Olink Genomics is participating in the project "Companion Diagnostics Initiative" which is financed by Vinnova and aims to develop improved cancer diagnostics to increase survival rate of patients with colorectal cancer. The project is coordinated by ...

PolyTherics and Minapharm Pharmaceuticals Sign Collaboration Agreement to Create Enhanced Biopharmaceuticals

15-Sep-2009 - PolyTherics Limited announced the initiation of a research collaboration agreement with Minapharm Pharmaceuticals. PolyTherics will apply its proprietary drug modification technologies to a target protein of commercial interest to Minapharm. Minapharm has an option to license the collaboration ...

Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG

ESBATech shareholders retain rights to non-ophthalmic technology and products

15-Sep-2009 - Alcon announced that it has entered into a definitive agreement to acquire ESBATech AG. Alcon will pay ESBATech shareholders $150 million in cash at closing, plus contingent payments of up to $439 million based upon the achievement of future research and development milestones that would be ...

IBA BioTAGnology goes India

15-Sep-2009 - IBA GmbH was represented at the Bangalore Bio at a joint booth with BMBF. The aim was, according to IBA´s CSO and Managing Director Dr. Joachim Bertram, a product presentation in the field of Life Sciences as well as a strengthening of the research co-operations in India. In this highly ...

FAB Pharma raises €2.3 million in series A funding and begins recruitment for a Phase I trial of its lead compound

15-Sep-2009 - FAB Pharma announced the completion of a €2.3 million round of series A funding led by CDC innovation and co-led by Bioam Gestion. The USA-based, healthcare-focused hedge fund Redmile Group also participated in the round. FAB Pharma has acquired assets in the treatment of methicillin-resistant ...